Phase 3 Study of S-217622 in the Prevention of Symptomatic SARS_CoV-2 Infection
Clinical Trial Grant
Administered By
Duke Clinical & Translational Science Institute
Awarded By
Shionogi Inc.
Start Date
July 31, 2024
End Date
November 13, 2024
Administered By
Duke Clinical & Translational Science Institute
Awarded By
Shionogi Inc.
Start Date
July 31, 2024
End Date
November 13, 2024